Zydus Lifesciences Limited (NSE:ZYDUSLIFE)

Zydus Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	11,051	5,731	11,069	8,883	9,649
Short-Term Investments	-	-	-	5,134	-	687
Trading Asset Securities	-	2,525	6,193	23,532	1,989	2,128
Cash & Short-Term Investments	24,950	13,576	11,924	39,735	10,872	12,464
Cash Growth	64.20%	13.85%	-69.99%	265.48%	-12.77%	41.77%
Accounts Receivable	-	52,202	44,168	33,403	31,273	36,632
Other Receivables	-	3,551	2,181	1,991	2,832	2,353
Receivables	-	55,768	46,353	35,394	34,105	38,985
Inventory	-	34,419	34,133	37,194	32,362	27,890
Prepaid Expenses	-	1,021	1,016	721	908	761
Other Current Assets	-	9,414	6,656	7,908	8,913	7,054
Total Current Assets	-	114,198	100,082	120,952	87,160	87,154
Property, Plant & Equipment	-	69,148	68,267	64,226	63,332	61,937
Long-Term Investments	-	9,696	11,779	9,348	6,312	5,522
Goodwill	-	52,660	48,044	53,646	53,465	53,915
Other Intangible Assets	-	26,110	10,905	11,272	12,363	13,868
Long-Term Deferred Tax Assets	-	16,442	12,624	10,958	10,744	8,529
Other Long-Term Assets	-	4,554	5,843	7,552	5,471	5,941
Total Assets	-	292,808	257,564	277,954	238,847	236,866
Accounts Payable	-	21,267	21,250	21,378	22,059	20,443
Accrued Expenses	-	15,385	15,454	13,118	11,123	10,463
Short-Term Debt	-	7,863	10,812	33,142	30,785	38,265
Current Portion of Long-Term Debt	-	-	822	5,198	9,031	9,453
Current Portion of Leases	-	105	119	88	90	129
Current Income Taxes Payable	-	3,720	1,568	418	884	291
Other Current Liabilities	-	5,079	5,282	5,052	4,641	3,650
Total Current Liabilities	-	53,419	55,307	78,394	78,613	82,694
Long-Term Debt	-	-	-	3,621	6,095	32,146
Long-Term Leases	-	251	198	161	151	145
Long-Term Unearned Revenue	-	431	295	287	227	199
Long-Term Deferred Tax Liabilities	-	4,465	1,944	1,538	1,197	2,099
Other Long-Term Liabilities	-	10,129	219	165	173	127
Total Liabilities	-	71,792	60,681	87,416	89,551	119,762
Common Stock	-	1,006	1,012	1,024	1,024	1,024
Retained Earnings	-	206,062	181,163	172,855	131,739	104,048
Comprehensive Income & Other	-	-8,773	-7,017	-3,883	-2,840	-1,315
Total Common Equity	218,246	198,295	175,158	169,996	129,923	103,757
Minority Interest	-	22,721	21,725	20,542	19,373	13,347
Shareholders' Equity	241,546	221,016	196,883	190,538	149,296	117,104
Total Liabilities & Equity	-	292,808	257,564	277,954	238,847	236,866
Total Debt	1,905	8,219	11,951	42,210	46,152	80,138
Net Cash (Debt)	23,045	5,357	-27	-2,475	-35,280	-67,674
Net Cash Per Share	22.88	5.29	-0.03	-2.42	-34.46	-66.10
Filing Date Shares Outstanding	1,006	1,006	1,012	1,024	1,024	1,024
Total Common Shares Outstanding	1,006	1,006	1,012	1,024	1,024	1,024
Working Capital	-	60,779	44,775	42,558	8,547	4,460
Book Value Per Share	217.00	197.07	173.05	166.05	126.91	101.35
Tangible Book Value	136,227	119,525	116,209	105,078	64,095	35,974
Tangible Book Value Per Share	135.45	118.78	114.81	102.64	62.61	35.14
Land	-	6,170	6,258	5,727	5,701	5,406
Buildings	-	21,906	20,748	19,688	20,454	18,841
Machinery	-	80,775	74,985	71,260	65,598	61,533
Construction In Progress	-	11,115	11,302	6,610	7,832	7,415

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.